{"id":"https://openalex.org/W4400876016","doi":"https://doi.org/10.1007/s40487-024-00285-4","title":"Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong","display_name":"Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong","publication_year":2024,"publication_date":"2024-07-22","ids":{"openalex":"https://openalex.org/W4400876016","doi":"https://doi.org/10.1007/s40487-024-00285-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/39037537","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11333381"},"language":"en","primary_location":{"id":"doi:10.1007/s40487-024-00285-4","doi":"https://doi.org/10.1007/s40487-024-00285-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40487-024-00285-4","pdf_url":null,"source":{"id":"https://openalex.org/S4210187091","display_name":"Oncology and Therapy","issn_l":"2366-1070","issn":["2366-1070","2366-1089"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s40487-024-00285-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025137857","display_name":"Ava Kwong","orcid":"https://orcid.org/0000-0002-6968-9489","observed_orcids":["https://orcid.org/0000-0002-6968-9489"]},"institutions":[{"id":"https://openalex.org/I889458895","display_name":"University of Hong Kong","ror":"https://ror.org/02zhqgq86","country_code":"HK","type":"education","lineage":["https://openalex.org/I889458895"]}],"countries":["HK"],"is_corresponding":true,"raw_author_name":"Ava Kwong","raw_affiliation_strings":["Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China. avakwong@hku.hk","Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China"],"raw_orcid":"https://orcid.org/0000-0002-6968-9489","affiliations":[{"raw_affiliation_string":"Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China. avakwong@hku.hk","institution_ids":["https://openalex.org/I889458895"]},{"raw_affiliation_string":"Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China","institution_ids":["https://openalex.org/I889458895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114207063","display_name":"Roland Ching-Yu Leung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800810863","display_name":"Queen Mary Hospital","ror":"https://ror.org/02xkx3e48","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I2800810863"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Roland Leung","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Department of Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong SAR, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Department of Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong SAR, China","institution_ids":["https://openalex.org/I2800810863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086248152","display_name":"Tsz Ching Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I889458895","display_name":"University of Hong Kong","ror":"https://ror.org/02zhqgq86","country_code":"HK","type":"education","lineage":["https://openalex.org/I889458895"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Tsz Ching Chan","raw_affiliation_strings":["Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China","institution_ids":["https://openalex.org/I889458895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078030732","display_name":"Anvi Khandelwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anvi Khandelwal","raw_affiliation_strings":["Complete Health Economics and Outcomes Research Solutions (CHEORS), North Wales, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Complete Health Economics and Outcomes Research Solutions (CHEORS), North Wales, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kshama Mishra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kshama Mishra","raw_affiliation_strings":["Complete Health Economics and Outcomes Research Solutions (CHEORS), North Wales, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Complete Health Economics and Outcomes Research Solutions (CHEORS), North Wales, PA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079060977","display_name":"Min Huang","orcid":"https://orcid.org/0000-0003-1960-4552","observed_orcids":["https://orcid.org/0000-0003-1960-4552"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Huang","raw_affiliation_strings":["Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5025137857"],"corresponding_institution_ids":["https://openalex.org/I889458895"],"apc_list":{"value":6850,"currency":"USD","value_usd":6850},"apc_paid":{"value":6850,"currency":"USD","value_usd":6850},"fwci":1.4163,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.83265653,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"12","issue":"3","first_page":"525","last_page":"547"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8809999823570251},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8640000224113464},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.8149999976158142},{"id":"https://openalex.org/keywords/locoregional-recurrence","display_name":"locoregional recurrence","score":0.8040000200271606},{"id":"https://openalex.org/keywords/distant-metastasis","display_name":"distant metastasis","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.853864312171936},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7760410308837891},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6489362120628357},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5178837776184082},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47791844606399536},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.474685400724411},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4455139935016632},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.4122743308544159},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27888354659080505},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.10297584533691406},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1007/s40487-024-00285-4","doi":"https://doi.org/10.1007/s40487-024-00285-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40487-024-00285-4","pdf_url":null,"source":{"id":"https://openalex.org/S4210187091","display_name":"Oncology and Therapy","issn_l":"2366-1070","issn":["2366-1070","2366-1089"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11333381","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11333381","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11333381/pdf/40487_2024_Article_285.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncol Ther","raw_type":"Text"},{"id":"pmid:39037537","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39037537","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:499f6d95549e4000968fd31438b2f8fc","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/499f6d95549e4000968fd31438b2f8fc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Oncology and Therapy, Vol 12, Iss 3, Pp 525-547 (2024)","raw_type":"article"},{"id":"pmh:oai:hub.hku.hk:10722/344714","doi":null,"is_oa":true,"landing_page_url":"https://hub.hku.hk/handle/10722/344714","pdf_url":null,"source":{"id":"https://openalex.org/S4377196271","display_name":"The HKU Scholars Hub (University of Hong Kong)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I889458895","host_organization_name":"University of Hong Kong","host_organization_lineage":["https://openalex.org/I889458895"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1007/s40487-024-00285-4","doi":"https://doi.org/10.1007/s40487-024-00285-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40487-024-00285-4","pdf_url":null,"source":{"id":"https://openalex.org/S4210187091","display_name":"Oncology and Therapy","issn_l":"2366-1070","issn":["2366-1070","2366-1089"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G396684313","display_name":null,"funder_award_id":"GMSA/231073","funder_id":"https://openalex.org/F4320332932","funder_display_name":"Merck Sharp and Dohme"}],"funders":[{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400876016.pdf","grobid_xml":"https://content.openalex.org/works/W4400876016.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1964323747","https://openalex.org/W2013564592","https://openalex.org/W2038981426","https://openalex.org/W2105455398","https://openalex.org/W2118605519","https://openalex.org/W2122317738","https://openalex.org/W2618058692","https://openalex.org/W2808672171","https://openalex.org/W2902859691","https://openalex.org/W2946918907","https://openalex.org/W3006930853","https://openalex.org/W3110194737","https://openalex.org/W3208194388","https://openalex.org/W4210957314","https://openalex.org/W4249747122","https://openalex.org/W4316928245"],"related_works":["https://openalex.org/W4316928245","https://openalex.org/W4388975291","https://openalex.org/W6921146675","https://openalex.org/W4229010420","https://openalex.org/W4410059081","https://openalex.org/W4413408816","https://openalex.org/W4283526032","https://openalex.org/W4390126158","https://openalex.org/W4284700853","https://openalex.org/W4390126340"],"abstract_inverted_index":{"The":[0,43,116,188,231,300,339,429,442],"phase":[1],"III":[2],"randomized":[3],"KEYNOTE-522":[4,114,123],"trial":[5,412],"demonstrated":[6],"that":[7,159,345],"pembrolizumab":[8,19,51,160,271,317,349],"in":[9,26,60,132,268,289,297,326,334,391],"combination":[10,347],"with":[11,36,62,76,102,165,263,294,328,427],"chemotherapy":[12,53,57,162,273,319,323,351],"as":[13,373],"neoadjuvant":[14,56,322],"treatment":[15],"followed":[16],"by":[17],"adjuvant":[18],"(pembrolizumab":[20],"+":[21,52,161,272,318],"chemotherapy)":[22],"provided":[23],"significant":[24],"improvements":[25],"event-free":[27],"survival":[28,32],"(EFS)":[29],"and":[30,85,95,109,139,171,179,197,236,249,266,305,350,358,414,433,451],"overall":[31],"(OS)":[33],"for":[34,223,259,292,376],"patients":[35,61,293,327],"high-risk":[37,63,264,295,329],"early-stage":[38,330],"triple-negative":[39,331],"breast":[40,332],"cancer":[41,333],"(eTNBC).":[42],"objective":[44],"was":[45,87,163,383,398],"to":[46,55,89,144,186,312,321,422],"assess":[47,90,145],"the":[48,91,113,146,207,242,253,256,269,279,285,303,314,335,342,346,364,379,395,405,424,438,448],"cost-effectiveness":[49,104,212,315,377,381],"of":[50,148,174,214,226,255,284,307,316,341,348,367,411,447],"compared":[54,185,320],"alone":[58,324],"(chemotherapy)":[59,325],"eTNBC":[64,265,296],"from":[65,112,122],"a":[66,151,166,260,275,308,374],"Hong":[67,134,224,290,298,336,392],"Kong":[68,135,225,337],"third-party":[69],"payer":[70],"perspective.":[71],"A":[72],"multistate":[73],"transition":[74],"model":[75,311],"four":[77],"health":[78,96,117,309],"states":[79],"(event-free),":[80],"locoregional":[81],"recurrence,":[82],"distant":[83],"metastases,":[84],"death)":[86],"developed":[88],"lifetime":[92],"medical":[93],"costs":[94],"outcomes":[97,413],"(3%":[98],"annual":[99],"discount),":[100],"along":[101],"incremental":[103,380],"ratios":[105],"(ICERs)":[106],"using":[107],"efficacy":[108],"safety":[110],"data":[111],"trial.":[115],"state":[118],"utilities":[119],"were":[120,130,142,191,204,244,440],"derived":[121],"Euro-QoL-five-dimension":[124],"five-level":[125],"questionnaire":[126],"(EQ-5D-5L)":[127],"data.":[128],"Costs":[129],"expressed":[131],"2022":[133],"dollars":[136],"(HKD).":[137],"Scenario":[138],"sensitivity":[140,233,238,416,431,435],"analyses":[141,234,432],"performed":[143,421],"robustness":[147],"results.":[149,428],"Over":[150],"32-year":[152],"time":[153],"horizon,":[154],"base":[155],"case":[156],"results":[157,243,306,340,406,439],"showed":[158,241,437],"associated":[164,426],"3.42":[167],"year":[168],"longer":[169],"EFS":[170],"expected":[172],"gains":[173],"3.05":[175,355],"life":[176,182,356,361],"years":[177,183,357],"(LYs)":[178],"2.45":[180,359],"quality-adjusted":[181,360],"(QALYs)":[184],"chemotherapy.":[187],"resultant":[189],"ICERs":[190],"HKD":[192,198,227],"135,200":[193],"per":[194,200,221,229,287,389],"QALY":[195],"gained":[196],"108,463":[199],"LY":[201],"gained,":[202],"which":[203],"lower":[205],"than":[206,385],"World":[208],"Health":[209],"Organization":[210],"(WHO)":[211],"threshold":[213],"three":[215,386],"times":[216,387],"gross":[217,369],"domestic":[218,370],"product":[219,371],"(GDP)":[220,372],"capita":[222,288,390],"1,171,308":[228],"QALY.":[230],"one-way":[232,430],"(OWSA)":[235],"probabilistic":[237,434],"analysis":[239,257,417,436],"(PSA)":[240],"robust":[245],"across":[246],"various":[247],"inputs":[248],"alternative":[250],"scenarios.":[251],"On":[252],"basis":[254],"conducted":[258],"56-year-old":[261],"cohort":[262],"assumptions":[267],"model,":[270],"represents":[274],"cost-effective":[276],"proposition":[277],"(as":[278],"ICER":[280],"is":[281],"approximately":[282],"35%":[283],"GDP":[286,388],"Kong)":[291],"Kong.":[299,393],"manuscript":[301,343,443],"outlines":[302],"methods":[304],"economic":[310,445],"estimate":[313],"setting.":[338],"show":[344],"provides":[352,444,452],"an":[353],"additional":[354],"years.":[362],"Despite":[363],"potential":[365],"drawbacks":[366],"employing":[368],"proxy":[375],"thresholds,":[378],"ratio":[382],"less":[384],"Therefore,":[394],"new":[396,449,453],"intervention":[397,450],"cost-effective.":[399],"However,":[400],"like":[401],"any":[402],"similar":[403],"study,":[404],"rely":[407],"substantially":[408],"on":[409],"extrapolation":[410],"thus":[415],"has":[418],"also":[419],"been":[420],"handle":[423],"uncertainty":[425],"robust.":[441],"evidence":[446],"clinical":[454],"insights.":[455]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-23T00:00:00"}